Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's disease - Wikidata - awgldk - TriplyDB

Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's disease

Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's disease

http://www.wikidata.org/entity/Q26866392

about

Menopause, obesity and inflammation: interactive risk factors for Alzheimer's disease Age-Associated Weight Gain, Leptin, and SIRT1: A Possible Role for Hypothalamic SIRT1 in the Prevention of Weight Gain and Aging through Modulation of Leptin Sensitivity Splicing factors control C. elegans behavioural learning in a single neuron by producing DAF-2c receptor Insulin in the nervous system and the mind: Functions in metabolism, memory, and mood Comorbidity and dementia: A nationwide survey in Taiwan.Type 2 diabetes and quality of life.Body-Brain Connections: The Effects of Obesity and Behavioral Interventions on Neurocognitive Aging.Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer's Disease.The LDL Receptor-Related Protein 1: At the Crossroads of Lipoprotein Metabolism and Insulin Signaling Modulation of hippocampal neural plasticity by glucose-related signaling.A Multi-Marker Genetic Association Test Based on the Rasch Model Applied to Alzheimer's Disease.Regional Brain Glucose Hypometabolism in Young Women with Polycystic Ovary Syndrome: Possible Link to Mild Insulin Resistance.A Genome-Wide Association Study of Attention Function in a Population-Based Sample of Children.Intranasal Insulin Prevents Anesthesia-Induced Spatial Learning and Memory Deficit in Mice Anti-Diabetic Activities of Gastrodia elata Blume Water Extracts Are Mediated Mainly by Potentiating Glucose-Stimulated Insulin Secretion and Increasing β-Cell Mass in Non-Obese Type 2 Diabetic Animals Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer's disease Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases.Role of Inflammation in Human Fatigue: Relevance of Multidimensional Assessments and Potential Neuronal Mechanisms.Hypothalamic ΔFosB prevents age-related metabolic decline and functions via SNS Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes.Role of Adiposity-Driven Inflammation in Depressive Morbidity.Awake, long-term intranasal insulin treatment does not affect object memory, odor discrimination, or reversal learning in mice.Glucose Transporters in Brain: In Health and in Alzheimer's Disease.FGF1 - a new weapon to control type 2 diabetes mellitus.Evaluation of dietary and lifestyle changes as modifiers of S100β levels in Alzheimer's disease.Type 3 Diabetes: Cross Talk between Differentially Regulated Proteins of Type 2 Diabetes Mellitus and Alzheimer's Disease.Diabesity and Brain Energy Metabolism: The Case of Alzheimer's Disease.Experimental Models of Maternal Obesity and Neuroendocrine Programming of Metabolic Disorders in Offspring The effect of intra-cerebroventricular injection of insulin on nociception of formalin test in non-diabetic and short-term diabetic rat models.Is Glaucoma a Neurodegeneration caused by Central Insulin Resistance: Diabetes Type 4?Insulin Resistance and Alzheimer's Disease: Bioenergetic Linkages.Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer's Disease.Rat brain glucose transporter-2, insulin receptor and glial expression are acute targets of intracerebroventricular streptozotocin: risk factors for sporadic Alzheimer's disease?Expression of apoptosis-regulatory genes in the hippocampus of rat neonates born to mothers with diabetes.Pharmacokinetics of Intranasal versus Subcutaneous Insulin in the Mouse.Membrane Aging as the Real Culprit of Alzheimer's Disease: Modification of a Hypothesis.Involvement of Luteinizing Hormone in Alzheimer Disease Development in Elderly Women.Reduction of Cognitive Decline in Patients with or at High Risk for Diabetes.The Biased G-Protein-Coupled Receptor Agonism Bridges the Gap between the Insulin Receptor and the Metabolic Syndrome.The Role of Stress-Induced O-GlcNAc Protein Modification in the Regulation of Membrane Transport.

P2860

Q21131065-A6EE5A75-FDB8-4456-B77F-C569BD6F04A9 Q26800025-12D82BB5-0A13-4F0B-BEEC-FB30368C70C9 Q27316202-591ADFA0-32FE-4969-B14F-73E85DEE2FA8 Q28079442-82C3D3AA-2627-4B47-AE5B-CE986F285FF9 Q33558758-FD55845B-202B-4F0B-955B-93E68E0DD140 Q33573159-CFD3ED63-FC11-4A2B-B11E-2318D6DAD338 Q33619524-207A2404-3D66-43FE-8E73-82C8B788F862 Q33628048-FF471939-9102-4EDB-A3C1-F96244434296 Q33726334-F500AAB9-AF66-4CF6-8585-A4C162C0B4A2 Q35568177-EA83CC0B-E3AA-4EE2-932A-57C8E38A3EBF Q35778648-B0DA86AD-F09D-4955-8D68-FE974F72B7A9 Q35864473-09F3D3F7-99D7-46AF-8315-6B7B4C67D87E Q36140499-EE89F9A6-9975-4864-8EE7-171853EAD273 Q36583411-CF9AED0A-BC0A-412D-BC3E-E50ACACA160A Q36732130-5693C97E-9601-40E7-803D-5F4C497D0E68 Q37208538-D261C5D1-AFBA-410D-9393-46526919AE56 Q37474214-8A94EE42-B61C-4A6E-A6A1-92FBDA0A0C4C Q37595009-49360060-6D32-45A4-B19A-5B998A8E4F45 Q37715487-EBEC1413-CB49-42D8-8055-B470E2D43786 Q38524435-05B6654A-BA70-4B88-9921-B64F879E78E1 Q38893391-7CF4697B-D645-4BCA-A170-4D33AB63E20E Q38929334-14ED211D-B3F7-4D5E-920A-2E44C542ECBA Q39012005-2C50E730-3234-42BF-AD27-4BD77EC57575 Q39406663-6F54F7AA-F9DB-4918-8909-1211A066C6E6 Q39428145-85D9E24C-FF03-49CB-A492-99277D9C1684 Q41087317-3F4C6BEE-58BE-425B-8FC1-DDB29FE17956 Q41995767-6EE99918-E046-446D-938A-802654052E03 Q42109185-ADBB8BC3-44D7-4956-A2A0-99006F1E2E47 Q42339361-7C638A94-E535-43AB-B98E-756D56CFF740 Q44707873-F6B997A4-51DE-417A-84AF-3E25D8A6E884 Q46799102-7287D771-11CA-43A6-8B96-E3C77CF128FB Q47149070-83379147-69A3-49DE-BC88-42DD59D9B960 Q47732929-EEAF2581-FC8F-4B8F-83AB-29D79EB6D78A Q47893218-E3023CBD-BF00-4DCD-AE94-55FBDFD4FC77 Q47906548-BDBD09C0-8FA4-4E9C-B815-CD77FDAC400D Q47949218-1438C14D-6881-4D8F-86F5-6295FFDB5BAC Q48614782-AF913123-E8D6-441B-AC39-304AF5066E3B Q49687656-FDC65B80-D0D4-4432-8214-4238896F0DE3 Q49804487-A8102681-8242-478C-B252-6EB55B87C425 Q49874500-00FF1C26-4370-46A1-8443-000F8788858A

P2860

Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's disease

http://www.wikidata.org/entity/Q26866392

description

2014 nî lūn-bûn

@nan

2014 թուականին հրատարակուած գիտական յօդուած

@hyw

2014 թվականին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Insulin in the brain: its path ...... abetes and Alzheimer's disease

@ast

Insulin in the brain: its path ...... abetes and Alzheimer's disease

@en

Insulin in the brain: its path ...... abetes and Alzheimer's disease

@nl

type

label

Insulin in the brain: its path ...... abetes and Alzheimer's disease

@ast

Insulin in the brain: its path ...... abetes and Alzheimer's disease

@en

Insulin in the brain: its path ...... abetes and Alzheimer's disease

@nl

prefLabel

Insulin in the brain: its path ...... abetes and Alzheimer's disease

@ast

Insulin in the brain: its path ...... abetes and Alzheimer's disease

@en

Insulin in the brain: its path ...... abetes and Alzheimer's disease

@nl

P1433

Q26866392-1B90C7C9-82A0-4748-9257-21C290B52B20

P1476

Q26866392-DB94D8FA-8A8C-40B0-B712-0AE03E72DBC1

P2093

Q26866392-E83A30A2-DCF7-4B80-B52F-E651D5B48676

Q26866392-F43CF437-F24A-4DB0-B265-AB7584C0A6AA

Q26866392-FA1964B3-BBB6-4EE0-8309-15BD7439CDAB

P2860

Q26866392-0038D85F-4C6F-49B5-9272-EC7025777F20

Q26866392-019B5923-2CED-445F-97BF-7C23838FC599

Q26866392-01B5D76F-779B-48CC-BCCC-70BBD827A686

Q26866392-043EFAF1-B209-4FCE-B1C3-EC94764FD226

Q26866392-04D47ADA-D62B-4F36-9F11-205F2949F32C

Q26866392-05301B04-612B-4B39-AEBE-C92E794DB039

Q26866392-05B52805-38A4-4771-BD18-5DC928D8C686

Q26866392-060FC582-EB24-4BD8-B734-377F1480D479

Q26866392-06BA0220-D151-412D-9D5D-B33BBBA62AE2

Q26866392-06D8BC27-2FC2-41D2-BEF2-37E73EE8F1C9

P304

Q26866392-1DBBDE34-02E1-4071-B4D8-9FD58B8EEE3D

P31

Q26866392-D7528870-4C1C-4932-8BA6-AD951F4CAE8E

P3181

Q26866392-FF8879F9-B73C-46E0-83E3-9308CE972B1B

P356

Q26866392-171CF35F-5888-4C1C-90F2-C55A042DE6BA

P407

Q26866392-FA338913-3696-4FDA-A2A2-62996F22B2E6

P478

Q26866392-71D9909E-B2CC-4E47-A860-5C11026F64FF

P50

Q26866392-03779190-E24E-428A-8EC5-AA2C8896972F

P577

Q26866392-9C632E7A-C21C-4036-9F5F-CE18E4716B59

P5875

Q26866392-EA24371C-8D75-4015-9750-643ADA425811

P698

Q26866392-CFB50114-2947-4234-8A10-3AF66CC8DD7E

P921

Q26866392-19E40B68-27D6-48F3-B6A6-69855F9794C3

Q26866392-1F95E891-4898-4AAF-916C-9BB47684FA2B

Q26866392-6602FCB0-338F-4FDE-8D50-B7A7864929F1

Q26866392-D7A58DEE-73DC-4A71-92E2-DB1ABC8FC246

Q26866392-E5D80105-66C0-4845-BBC4-C7A485C07200

P932

Q26866392-EC5DB2CF-28B2-434D-8517-373A8C098915

P3181

P356

FENDO.2014.00161

P1433

Frontiers in Endocrinology

P1476

Insulin in the brain: its path ...... abetes and Alzheimer's disease

@en

P2093

Esther Velázquez

http://www.w3.org/2001/XMLSchema#string

Juan Miguel Ruiz-Albusac

http://www.w3.org/2001/XMLSchema#string

Verónica Hurtado-Carneiro

http://www.w3.org/2001/XMLSchema#string

P2860

Role of Infection in the Pathogenesis of Alzheimerʼs Disease

Regional and cellular distribution patterns of insulin-degrading enzyme in the adult human brain and pituitary

Inflammation, stress, and diabetes

Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease

Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo

Insulin signaling inhibits the 5-HT2C receptor in choroid plexus via MAP kinase

Insulin in the brain: there and back again

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

Inflammation and Alzheimer's disease

The insulin receptor tyrosine kinase substrate p58/53 and the insulin receptor are components of CNS synapses

P304

161

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1480038

http://www.w3.org/2001/XMLSchema#string

P356

10.3389/FENDO.2014.00161

http://www.w3.org/2001/XMLSchema#string

P407

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Enrique Blazquez

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267738562

http://www.w3.org/2001/XMLSchema#string

P698

25346723

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

pathophysiology

type-2 diabetes

P932

4191295

http://www.w3.org/2001/XMLSchema#string